BioCentury
ARTICLE | Management Tracks

New CEOs for Enable, StromaCare

Plus: Philippakis joins GV as general partner, and updates from Verily, Meliora, Citryll and Silver Creek

February 14, 2024 1:37 AM UTC

Drug discovery company Enable Medicine Inc. named Kamni Vijay as CEO, succeeding Sunil Bodapati, who will become chief strategy officer while remaining chairman. Vijay was VP and general manager at Becton Dickinson and Co. (NYSE:BDX) and at Bio-Techne Corp. (NASDAQ:TECH). 

StromaCare, a French company developing cancer therapies through stroma modulation, hired Georges Rawadi as CEO. Rawadi was CEO of Celyad Oncology S.A. (Euronext:CYAD; Pink:CYADY) and Ysopia Biosciences S.A. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article